Golestani reports 20.9% stake in Zapata Quantum
Clark Golestani filed Amendment No. 2 to his Schedule 13D for Zapata Quantum, Inc. after the company voluntarily registered its common stock under Section 12(g) and became a mandatory reporting company.
Rhea-AI Filing Summary
Clark Golestani filed Amendment No. 2 to his Schedule 13D for Zapata Quantum, Inc. after the company voluntarily registered its common stock under Section 12(g) and became a mandatory reporting company. He beneficially owns 36,820,792 shares, or 20.9% of the 172,293,506 shares outstanding as of March 23, 2026.
His holdings include 32,500,000 restricted shares vesting over two years, additional common shares, multiple stock option grants with exercise prices between $0.08 and $3.80 per share, a convertible promissory note convertible at $0.04 per share, and a warrant exercisable at $0.04 per share. He states he acquired these securities with the purpose of exercising control as a director.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
convertible promissory note financial
warrant financial
beneficially owns financial
sole Voting Power financial
dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Zapata Quantum (ZPTA) does Clark Golestani report in this Schedule 13D/A?
Why was this Zapata Quantum (ZPTA) Schedule 13D Amendment No. 2 filed?
What is Zapata Quantum (ZPTA) required to do as a mandatory reporting company?
What role does Clark Golestani hold at Zapata Quantum (ZPTA)?
What stock option terms are disclosed for Clark Golestani in Zapata Quantum (ZPTA)?
AI-generated analysis. How Rhea-AI works. Not financial advice.